calmidazolium has been researched along with Bone Neoplasms in 1 studies
calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.
Bone Neoplasms: Tumors or cancer located in bone tissue or specific BONES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In human MG63 osteosarcoma cells, the effect of calmidazolium on [Ca(2+)](i) and proliferation was explored using fura-2 and ELISA, respectively." | 7.72 | Effect of calmidazolium on Ca(+2) movement and proliferation in human osteosarcoma cells. ( Chang, HT; Chen, JS; Cheng, HH; Hsu, SS; Huang, CJ; Jan, CR; Jiann, BP; Tseng, LL, 2004) |
| "In human MG63 osteosarcoma cells, the effect of calmidazolium on [Ca(2+)](i) and proliferation was explored using fura-2 and ELISA, respectively." | 3.72 | Effect of calmidazolium on Ca(+2) movement and proliferation in human osteosarcoma cells. ( Chang, HT; Chen, JS; Cheng, HH; Hsu, SS; Huang, CJ; Jan, CR; Jiann, BP; Tseng, LL, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tseng, LL | 1 |
| Huang, CJ | 1 |
| Hsu, SS | 1 |
| Chen, JS | 1 |
| Cheng, HH | 1 |
| Chang, HT | 1 |
| Jiann, BP | 1 |
| Jan, CR | 1 |
1 other study available for calmidazolium and Bone Neoplasms
| Article | Year |
|---|---|
Effect of calmidazolium on Ca(+2) movement and proliferation in human osteosarcoma cells.
Topics: Bone Neoplasms; Calcium; Calcium Signaling; Cell Line, Tumor; Cell Proliferation; Dose-Response Rela | 2004 |